WebMD Medical News
Daniel J. DeNoon
Laura J. Martin, MD
Jan. 27, 2011 -- The CDC has issued early recommendations for the use of AIDS drugs to prevent HIV infection of men who have high-risk sex with men.
The preliminary guidelines follow last November's groundbreaking report that daily use of the AIDS drug Truvada lowers men's risk of HIV infection. This strategy, called pre-exposure prophylaxis or PrEP, can cut HIV risk by as much as 92% in men who take the pill every day.
But there's a catch. Several catches. For example:
U.S. public health agencies are developing PrEP guidelines. But since the news is out -- and men already are asking their doctors whether PrEP is right for them -- the CDC today issued preliminary guidelines.
Since PrEP was tested only in men (and male-to-female transgendered women), PrEP should be given only to biological males. Men eligible for PrEP should be at high risk of HIV infection -- that is, they should frequently change sexual partners or have concurrent partners in a region with high HIV prevalence.
Here's the CDC's basic advice:
Before starting PrEP:
When starting PrEP:
When PrEP is discontinued:
The CDC's full preliminary PrEP guidelines appear in the Jan. 28 issue of Morbidity and Mortality Weekly Report.
SOURCE:Morbidity and Mortality Weekly Report, Jan. 28, 2011; vol 60: pp 65-68.
Here are the most recent story comments.View All
The views expressed here do not necessarily represent those of FOX23 News.
The Health News section does not provide medical advice, diagnosis or treatment. See additional information.